Wyniki wyszukiwania - Biblioteka Nauki

1

Almost sure limit theorems for dependent random variables

100%

Seweryn M.

Banach Center Publications

|

2010

|

tom 90

|

nr 1

171-178

EN

For a sequence of dependent random variables $(X_{k})_{k∈ℕ}$ we consider a large class of summability methods defined by R. Jajte in \cite{jaj} as follows: For a pair of real-valued nonnegative functions g,h: ℝ⁺ → ℝ⁺ we define a sequence of "weighted averages" $1/g(n) ∑_{k=1}^{n} (X_{k})/h(k)$, where g and h satisfy some mild conditions. We investigate the almost sure behavior of such transformations. We also take a close look at the connection between the method of summation (that is the pair of functions (g,h)) and the coefficients that measure dependence between the random variables.

2

Finansowanie najdroższych terapii lekowych w Polsce a problemy w dostępie do nich. Analiza poziomu finansowania i opłacalności programów terapeutycznych

51%

Seweryn M. , Koperny M. , Drobisz-Miętkiewicz A.

|

nr 2

97–104

EN

One of the most discussed topics about organization of the Polish health care system is providing full accessibility to the financing of the latest drug therapies. According to the institutions implementing the programs most serious causes of problems in access to innovative pharmacotherapy are too low level of funding programs and their low profitability, or even hospitals pay the extra to such benefits. Due to the increasingly high cost of treatment of severe illnesses and ongoing development of new medical technologies, in choosing the method of treatment are taken into account the results of economic analyzes. The authors, by analyzing the level of funding and implementation of treatment programs, have attempted to answer the question whether the claims are true, and health care providers and Polish patients have equal access to the most expensive drug therapies? To verify the above hypothesis also performed an cost analysis of selected therapeutic programs. Cost analysis conducted based on the identification and analysis of the costs of four therapeutic health programs indicated that the refund value of National Health Fund for providers implementing health programs may be substantially higher than the costs incurred by them. The current way of financing most expensive innovation therapy has many weaknesses, but most frequently mentioned causes of the problems with the availability of treatment programs are not supported by actual data.

3

Production lost due to cervical cancer in Poland in 2012

51%

Dubas-Jakóbczyk K. , Kocot E. , Seweryn M. , Koperny M.

Medycyna Pracy

|

2016

|

tom 67

|

nr 3

289-299

PL

Wstęp Polska ma jeden z najwyższych w Europie wskaźników umieralności kobiet z powodu nowotworu szyjki macicy. Niewiele kobiet uczestniczy w programach przesiewowych, a u wielu choroba jest późno diagnozowana. Celem badania było oszacowanie produkcji utraconej z powodu występowania nowotworu szyjki macicy w Polsce w 2012 r., a tym samym ocena wpływu choroby na zdolność populacji do pracy. Analizę można traktować również jako przykład metodyki szacowania strat produkcyjnych z powodu występowania określonej jednostki chorobowej przy wykorzystaniu dostępnych w Polsce danych. Materiał i metody Wykorzystano metodę kapitału ludzkiego i oszacowano produkcję utraconą z 4 powodów – 1) czasowej niezdolności do pracy, 2) trwałej niezdolności do pracy, 3) opieki członków rodziny nad osobą chorą i 4) umieralności – w kategoriach monetarnych i ilościowych (dni utraconej produkcji). Wyniki Nowotwór szyjki macicy spowodował w 2012 r. utratę 702 964 dni produkcji z powodu chorobowości i 957 678 dni z powodu umieralności. Całkowitą produkcję utraconą oszacowano na 111,4 mln euro, z czego ponad 66% było spowodowanych zgonami osób chorych na nowotwór. Wnioski Oszacowanie produkcji utraconej z powodu nowotworu szyjki macicy dostarcza silnych argumentów w procesie alokacji zasobów w sektorze zdrowia na rzecz prewencji nowotworów. Należy zintensyfikować również działania z zakresu promocji badań przesiewowych, m.in. z uwzględnieniem roli pracodawcy. Med. Pr. 2016;67(3):289–299

EN

Background Poland has one of the highest cervical cancer mortality rates in Europe. It is related to the problem of late diagnosis and low attendance rate in screening programs. The objective of the study has been to assess the annual production loss due to the cervical cancer morbidity and mortality in Poland in 2012. The outcomes have been to provide comprehensive information on cervical cancer’s influence on population’s ability to work and its overall economic burden for the society. The study has also provided the methodological framework for disease-related production losses in Polish settings. Material and Methods The human capital method was used. The production losses were calculated in both monetary and quantitative terms (working days lost) due to 4 following reasons: 1) temporary disability to work, 2) permanent disability, 3) informal care, and 4) mortality. Results Cervical cancer resulted in approx. 702 964 working days lost in 2012 due to absence at work for both patients and care givers and a total number of 957 678 working days lost due to patients’ mortality. The total value of production lost was assessed at 111.4 million euros. More than 66% of this value was attributed to women’s mortality. Conclusions The calculation of production lost due to cervical cancer burden provides strong evidence to support adequate health promotion and disease prevention actions. Actions promoting cervical cancer screening should be intensified including workplace health promotion activities. Med Pr 2016;67(3):289–299

4

Ogniska zakażeń szpitalnych w województwie małopolskim w latach 2011-2013

45%

Bandoła K. , Seweryn M. , Koperny M. , Bała M. M. , Mikos M.

|

tom 12

|

nr 2

PL

Despite the continuous advances of medicine and higher safety standards for patients, nosocomial infections are a major problem accompanying of treatment process. Infected patients are exposed to prolonged hospital stay, require additional medical procedures, theresofore their treatment and care are associated with additional costs for health facility. In the present study the number of outbreaks of nosocomial infections, which occurred in hospitals in the Malopolska province and in Poland, as well as etiological factors of the infections in the years 2011–2013 were analyzed. In the analyzed period we observed increase in the number of outbreaks of infections in Poland and in Malopolska (from 339 to 394 and from 19 to 26 in Poland and Malopolska respectively). The most frequently identified factor is C. difficile and Rotavirus, followed by K. pneumoniae ESBL, and Norovirus. There was a decrease in the number of outbreaks of unknown etiology, both in Poland and in Malopolska. The analysis identified an increase in the number of outbreaks caused by C. difficile, Noroviruses and Rotaviruses, as the main problem in the recent years. This trend occurs in the Malopolska region and in the country. However, the analysis of the reports shows improved reportability of outbreaks in Malopolska and in Poland which will allow for better control of nosocomial infections.